Titre :
  • Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium.
Auteur : Neymark, Niels ; Gorlia, Thierry ; Adriaenssen, Ines ; Baron, Benoît ; Piccart-Gebhart, Martine
Informations sur la publication : PharmacoEconomics, 20, 7, (page 485-497)
Statut de publication : Publié, 2002
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Antineoplastic Combined Chemotherapy Protocols -- economics
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Cisplatin -- administration & dosage
Cost-Benefit Analysis
Cyclophosphamide -- administration & dosage
Female
Health Care Costs
Humans
Ovarian Neoplasms -- drug therapy
Ovarian Neoplasms -- mortality
Paclitaxel -- administration & dosage
Note : Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1170-7690 
info:pii/200706
info:pmid/12093304